Amarantus Bioscience Holdings EBITDA 2010-2016 | AMBS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amarantus Bioscience Holdings ebitda from 2010 to 2016. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Amarantus Bioscience Holdings ebitda from 2010 to 2016. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$147B
CVS Health (CVS)	$91.5B
Elevance Health (ELV)	$69.9B
Cencora (COR)	$56.2B
DiDi Global (DIDIY)	$27.4B
Natera (NTRA)	$23B
Labcorp Holdings (LH)	$22.9B
BioMerieux (BMXMF)	$17.4B
EUROFINS SCIENT (ERFSF)	$14.6B
ICON (ICLR)	$14.1B
Medpace Holdings (MEDP)	$13.3B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.6B
Viatris (VTRS)	$12.1B
Caris Life Sciences,�Inc (CAI)	$10.8B
Revvity (RVTY)	$10.4B
Avantor (AVTR)	$9B
Charles River Laboratories (CRL)	$8B
Sonic Healthcare (SKHHY)	$7.8B
HealthEquity (HQY)	$7.6B
Bausch + Lomb (BLCO)	$5.2B
Sotera Health (SHC)	$4.6B
BrightSpring Health Services (BTSG)	$4.2B
Amplifon S.p.A (AMFPF)	$3.9B
GeneDx Holdings (WGS)	$3.7B
Alignment Healthcare (ALHC)	$3.2B
Concentras Parent (CON)	$3B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.4B
KindlyMD (NAKA)	$2.2B